|
NFU1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.233350E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.392900E-04 |
| Normal-vs-Stage2 |
4.558000E-02 |
| Normal-vs-Stage3 |
5.69769999999581E-05 |
| Normal-vs-Stage4 |
1.27559999996141E-06 |
| Stage1-vs-Stage2 |
7.370400E-01 |
| Stage1-vs-Stage3 |
8.763500E-02 |
| Stage1-vs-Stage4 |
1.474380E-02 |
| Stage2-vs-Stage3 |
1.746600E-01 |
| Stage2-vs-Stage4 |
4.993900E-02 |
| Stage3-vs-Stage4 |
3.338400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.71079999997404E-06 |
| Normal-vs-AfricanAmerican |
7.395500E-02 |
| Normal-vs-Asian |
9.942300E-03 |
| Caucasian-vs-AfricanAmerican |
2.185600E-01 |
| Caucasian-vs-Asian |
1.582180E-01 |
| AfricanAmerican-vs-Asian |
8.513800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.47089999999761E-05 |
| Normal-vs-Female |
4.159000E-04 |
| Male-vs-Female |
2.904000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.216400E-04 |
| Normal-vs-Age(41-60Yrs) |
3.631700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.014100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.258150E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.980800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.082200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.174990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.521600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.898370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.489000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.577500E-02 |
| Classical-VS-Follicular |
5.304100E-02 |
| Classical-VS-Other |
1.760400E-01 |
| Classical-VS-Normal |
1.93907999999077E-05 |
| Tall-VS-Follicular |
2.078700E-03 |
| Tall-VS-Other |
7.493400E-01 |
| Tall-VS-Normal |
2.16760000004701E-06 |
| Follicular-VS-Other |
1.421410E-01 |
| Follicular-VS-Normal |
1.346560E-01 |
| Other-VS-Normal |
3.883900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.417510E-03 |
| Normal-vs-N1 |
7.64940000230752E-08 |
| N0-vs-N1 |
1.241570E-03 |
|
|
